Loading...
XSHG
600530
Market cap608mUSD
Jul 10, Last price  
5.34CNY
1D
0.19%
1Q
1.52%
Jan 2017
-28.80%
IPO
-15.87%
Name

Shanghai Jiaoda Onlly Co Ltd

Chart & Performance

D1W1MN
XSHG:600530 chart
P/E
1,184.85
P/S
13.17
EPS
0.00
Div Yield, %
0.22%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
-1.14%
Revenues
314m
-3.40%
504,978,166568,271,302332,748,537315,318,138338,984,391350,940,124375,271,862357,075,713338,633,959251,925,780253,453,334269,963,735249,037,020332,602,653332,695,487362,576,663377,150,264296,327,064325,181,889314,115,346
Net income
3m
-88.54%
40,130,3135,109,737026,516,87658,004,74155,602,50283,152,25482,977,23784,871,37599,296,735137,201,052160,431,482-506,039,121-77,794,29192,670,126-8,915,713-498,621,758-35,084,38430,481,3673,492,475
CFO
23m
-63.63%
148,524,608158,622,9460127,813,62112,816,572020,014,7700022,967,27640,309,343012,473,57399,064,92667,178,715104,062,54098,270,10255,535,53663,379,03523,050,299
Dividend
Jun 09, 20250.0118 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai Jiaoda Onlly Co., Ltd., together with its various subsidiaries, primarily operates within China's health food sector. The company's product portfolio is extensive, featuring functional health items, probiotics, traditional tonics, dietary supplements, and natural extracts, alongside a range of disinfection solutions. Beyond health-related products, the firm is also engaged in the wholesale and retail distribution of pharmaceutical goods, as well as the production and sale of other food products. Further diversifying its operations, Shanghai Jiaoda Onlly provides road cargo and transportation services, in addition to offering travel agency activities. Headquartered in Shanghai, China, this company was founded in 1990.
IPO date
Jul 02, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT